Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz, Kimberly Meade‐White, Danielle Porter, Jonathan E. Schulz, Neeltje van Doremalen, Ian Leighton, Claude Kwe Yinda, Lizzette Pérez-Pérez, Atsushi Okumura, Jamie Lovaglio, Patrick W. Hanley, Greg Saturday, Catharine M. Bosio, Sarah L. Anzick, Kent Barbian, Tomáš Cihlář, Craig Martens, Dana Scott, Vincent J. Munster, Emmie de Wit
Topics & Concepts
MedicineRhesus macaqueCoronavirusVirologyViral loadMacaqueMiddle East respiratory syndrome coronavirusLungImmunologyIn vivoRespiratory systemVero cellViral sheddingClinical trialRespiratory tractDiseaseCoronavirus disease 2019 (COVID-19)VirusInternal medicineInfectious disease (medical specialty)BiologyPaleontologyBiotechnologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacological Receptor Mechanisms and Effects